)
Viemed Healthcare (VMD) investor relations material
Viemed Healthcare 2nd Annual Lytham Partners Healthcare Investor Summit summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business overview and differentiation
Specializes in home-based complex respiratory therapy, serving patients with severe COPD and neuromuscular diseases.
Diversified product mix includes sleep apnea, oxygen therapy, behavioral health, staffing, and maternal health.
High-touch model integrates respiratory therapists into hospital care teams and leverages proprietary technology for patient monitoring.
Sales process focuses on training clinicians as sales reps, creating a unique competitive advantage.
Strategic evolution and growth
Transitioned from a 90% ventilator-focused business to a diversified portfolio through organic growth and targeted M&A.
Published clinical data demonstrating reduced mortality and hospital admissions, establishing industry leadership.
Recent CMS national coverage determination (NCD) provides a regulatory edge and supports further expansion.
Completed three acquisitions to fill geographic and product gaps, notably Lehan's Medical for sleep and maternal health.
Financial performance and revenue streams
Achieved a 27% revenue CAGR, driven by expansion into underserved markets and growth in sleep apnea services.
Approximately 70% of revenue is recurring, primarily from equipment rentals; 30% is transactional.
Maintains positive net income and free cash flow, with low net debt and periodic share buybacks.
EBITDA margins are stable in the low 20% range, with potential for future expansion through operating leverage.
- TimeTickerHeadlineOpen
- NSKOG
Record recycled containerboard deliveries and improved liquidity, but profit declined. - NOV
2025 saw lower revenues and net income, but strong cash flow and robust shareholder returns. - PVRINOX
Revenue and profit improved year-over-year, with a notable one-time expense and asset sale. - NOD
Q4 revenue up 13% YoY to $170M, gross margin 54.9%, positive outlook for Q1 2026. - 543220
Strong revenue and profit growth, with major expansion and regulatory-driven exceptional items. - MARKSANS
Quarterly revenue and profit grew year-over-year, with global expansion and higher employee costs. - GN
Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming. - SUZLON
Q3 FY26 saw record deliveries, 42% revenue growth, and a robust 6.4 GW order book. - PN
Parcel growth and efficiency gains offset mail decline and Danish restructuring impacts. - KESKOB
Sales and profit rose in all divisions; 2026 outlook and €0.90 dividend proposal are positive.
Next Viemed Healthcare earnings date
Next Viemed Healthcare earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)